AVE 0.00% 0.2¢ avecho biotechnology limited

Ann: Avecho licenses TPM for use in cancer drugs, page-3

  1. 180 Posts.
    lightbulb Created with Sketch. 25
    Great news, the potential is evident as ever.
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.